(Q33851974)

29 July 2017

1 reference

title

Epidemiology of HIV/AIDS in children (English)

1 reference

29 July 2017

1 reference

1 reference

1

M L Lindegren

1 reference

29 July 2017

S Steinberg

2

1 reference

29 July 2017

R H Byers

series ordinal

3

1 reference

29 July 2017

publication date

1 February 2000

1 reference

Pediatric Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

47

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-20, v

1 reference

Surveillance of Pediatric HIV Infection

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Incubation periods for paediatric AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Projection of AIDS and HIV incidence among children born infected with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Tran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Trends in HIV prevalence among childbearing women in the United States, 1989-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Using surveillance data to monitor trends in the AIDS epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Prevalence of HIV infection in the United States, 1984 to 1992.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Trends in zidovudine prescription for pregnant women infected with HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Trends in perinatal transmission of HIV/AIDS in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Sexual abuse of children: intersection with the HIV epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The New York City Perinatal HIV Transmission Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Can Perinatal HIV Infection Be Eliminated in the United States?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Trends in transfusion-associated acquired immune deficiency syndrome in the United States, 1982 through 1991

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Medical issues related to caring for human immunodeficiency virus-infected children in and out of the home.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Worldwide prevention of vertical human immunodeficiency virus (HIV) transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970192-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70192-9

1 reference

29 July 2017

1 reference